Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholinergic Receptors: Nicotinic01:15

Cholinergic Receptors: Nicotinic

Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antitussive drugs--past, present, and future.

Pharmacological reviews·2014
Same author

The role of trigeminal nasal TRPM8-expressing afferent neurons in the antitussive effects of menthol.

Journal of applied physiology (Bethesda, Md. : 1985)·2013
Same author

Cholinergic brush cells in the trachea mediate respiratory responses to quorum sensing molecules.

Life sciences·2012
Same author

Sensory nerves and airway irritability.

Handbook of experimental pharmacology·2009
Same author

Cough sensors. I. Physiological and pharmacological properties of the afferent nerves regulating cough.

Handbook of experimental pharmacology·2008
Same author

Positive inotropic effect induced by sequence-specific Na+,K+-ATPase antibody in intact cardiac myocytes.

Annals of the New York Academy of Sciences·2003

Related Experiment Video

Updated: May 28, 2026

Localization of Plasma Membrane and Intracellular Neuronal Nicotinic Acetylcholine Receptors Using Quantitative Imaging in Mammalian Cells
09:06

Localization of Plasma Membrane and Intracellular Neuronal Nicotinic Acetylcholine Receptors Using Quantitative Imaging in Mammalian Cells

Published on: December 19, 2025

Nicotinic acetylcholine receptor assays.

B J Canning1

  • 1The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

Current Protocols in Pharmacology
|October 4, 2011
PubMed
Summary
This summary is machine-generated.

This study details methods for pharmacologically analyzing nicotinic acetylcholine receptors (nAChRs) in peripheral tissues. It focuses on isolated preparations to understand nAChR function in autonomic nerves and muscle.

More Related Videos

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
08:47

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration

Published on: February 10, 2012

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
10:04

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices

Published on: October 29, 2012

Related Experiment Videos

Last Updated: May 28, 2026

Localization of Plasma Membrane and Intracellular Neuronal Nicotinic Acetylcholine Receptors Using Quantitative Imaging in Mammalian Cells
09:06

Localization of Plasma Membrane and Intracellular Neuronal Nicotinic Acetylcholine Receptors Using Quantitative Imaging in Mammalian Cells

Published on: December 19, 2025

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
08:47

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration

Published on: February 10, 2012

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
10:04

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices

Published on: October 29, 2012

Area of Science:

  • Pharmacology
  • Neuroscience
  • Physiology

Background:

  • Peripheral nicotinic acetylcholine receptors (nAChRs) are primarily located on autonomic nerves and skeletal muscle motor end plates.
  • Understanding nAChR function is crucial for studying autonomic and neuromuscular signaling.
  • Existing methods allow for antagonist potency assessment via nerve stimulation or exogenous agonist application.

Purpose of the Study:

  • To describe and validate experimental preparations for studying peripheral nAChR pharmacology.
  • To provide techniques for assessing antagonist potencies at autonomic synapses and muscle nAChRs.
  • To detail methods for evaluating nAChR-mediated responses to exogenous agonists in smooth muscle.

Main Methods:

  • Utilized isolated guinea pig trachea/esophagus preparation to study nAChRs in parasympathetic and sympathetic nervous system synapses and esophageal striated muscle.
  • Described a preparation for studying nAChRs in the striated musculature of the diaphragm.
  • Developed techniques for assessing exogenous nicotinic agonist effects on nAChRs in two smooth muscle preparations.

Main Results:

  • Successfully demonstrated the utility of the described preparations for pharmacologic analysis of nAChRs.
  • Provided a framework for quantifying antagonist effects on nAChR-mediated responses in various peripheral tissues.
  • Established methods applicable to both nerve-stimulated and exogenously stimulated nAChR responses.

Conclusions:

  • The described experimental models offer robust platforms for detailed pharmacologic characterization of peripheral nAChRs.
  • These preparations facilitate the study of nAChR function in both neuronal and muscular compartments of the peripheral nervous system.
  • The methodologies presented are valuable for drug discovery and understanding the role of nAChRs in physiological processes.